Page
%P
-
Article
Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies
High rates of relapse and poor prognosis confer an urgent need for novel therapeutic agents for B cell non-Hodgkin lymphomas (B-NHLs). Herein, we describe a human IgG-like anti-CD79b/CD3 bispecific antibody (I...